Innovassynth investments announced its unaudited financial results for the quarter and nine months ended December 31, 2025, revealing challenging operational performance despite completing a significant corporate restructuring. The company, formerly known as Innovassynth Investments Limited, reported substantial losses during the reporting period.

Financial Performance Overview

The company's financial performance showed mixed results across different metrics during Q3FY26:

Nine-Month Performance Analysis

The nine-month period ending December 31, 2025, demonstrated significant operational challenges:

Merger Completion and Corporate Restructuring

A significant development during the quarter was the completion of the merger by absorption of associate company Innovassynth Technologies (India) Limited. The National Company Law Tribunal approved the scheme on November 14, 2025, with the merger becoming effective on December 19, 2025, when the order was filed with the Registrar of Companies.

As part of this merger, the company issued 4,74,65,031 additional equity shares with a face value of Rs. 10 each at an issue price of Rs. 29.39 each to erstwhile shareholders. This resulted in an increase in share capital by Rs. 13,949.97 lakh, comprising face value of Rs. 4,746.50 lakh and securities premium of Rs. 9,203.47 lakh.

Operational Expenses and Cost Structure

The company's expense structure during Q3FY26 included several key components:

• Cost of materials consumed: Rs. 1,468.42 lakh • Employee benefits expense: Rs. 920.68 lakh • Other expenses: Rs. 1,329.65 lakh • Finance costs: Rs. 188.83 lakh • Depreciation and amortisation: Rs. 197.39 lakh

Notably, the company recorded a positive impact from changes in inventories of Rs. 1,114.49 lakh, which partially offset other operational expenses.

Regulatory and Compliance Matters

The company disclosed the impact of New Labour Codes that became effective November 21, 2025. The consolidated labour legislation framework resulted in an incremental impact of Rs. 92.12 lakh on employee benefit expenses for the quarter and nine months ended December 31, 2025, primarily due to changes in wage definitions and recognition of past service costs.

Exceptional items totaling Rs. 50.22 lakh were recorded during the quarter, primarily related to merger-related expenses. The company's main business involves manufacturing specialty chemicals and pharmaceutical intermediates, with all other activities being incidental to the core operations.

Innovassynth Investments Limited has officially completed its transformation to Innovassynth Technologies (India) Limited following Ministry of Corporate Affairs approval on December 31, 2025. This name change represents the final step in the company's post-merger restructuring after the NCLT-approved merger with Innovassynth Technologies (India) Limited, which included substantial shareholding changes and regulatory filings under SEBI takeover regulations.

Official Name Change and Corporate Restructuring

The Ministry of Corporate Affairs approved the company's name change from "Innovassynth Investments Limited" to "Innovassynth Technologies (India) Limited" effective December 31, 2025. The transformation was executed pursuant to the merger scheme sanctioned by the National Company Law Tribunal, Mumbai Bench, with all necessary filings completed with BSE and the Registrar of Companies, Mumbai.

Share Allotment and Capital Enhancement

The Board of Directors approved the allotment of 4,74,65,031 equity shares of ₹10.00 each to shareholders of the transferor company. The allotment was executed based on a 1:1 share swap ratio, with December 19, 2025, serving as the record date for determining eligible shareholders.

Post allotment, the company's paid-up equity share capital increased to ₹75.45 crores, divided into 7.54 crore fully paid-up equity shares. These newly allotted shares rank pari-passu with existing equity shares and are proposed to be listed and traded on BSE Limited.

SEBI Regulation 10(6) Disclosure Filing

On December 24, 2025, the Raheja group filed comprehensive disclosures under Regulation 10(6) of SEBI Substantial Acquisition of Shares and Takeovers Regulations, 2011. The disclosure was filed following the acquisition of 4,68,05,250 equity shares through the merger scheme, which was exempt from open offer obligations under Regulation 10(1)(d)(ii).

Overall Promoter Group Shareholding Pattern

Following the merger completion, the total promoter group shareholding in the company increased substantially from 31.46% to 73.70%. The transformation resulted in the Raheja group becoming the controlling shareholders while existing promoters retained reduced but significant stakes.

Leadership Appointments and Board Restructuring

The board approved several key appointments as part of the post-merger integration strategy. Mr. Prosenjit Gupta was appointed as Chairperson of the company with immediate effect. Dr. Hardik Joshipura continues as Managing Director and was additionally appointed as Chief Executive Officer.

Regulatory Compliance and Merger Timeline

The merger by absorption was approved by the National Company Law Tribunal, Mumbai Bench, with the scheme becoming effective on December 19, 2025. All regulatory filing requirements were completed with the Ministry of Corporate Affairs under Section 232(5) of the Companies Act, 2013.